Abstract Library

#3156 To determine the true incidence of brain metastases in atypical lung neuroendocrine tumors and explore factors that increase the risk of intracranial disease

Introduction: Lung neuroendocrine tumors (NETs) make up 25% of all NETs. Typical carcinoid (TC) and atypical carcinoid (AC) account for 2% and 0.2% of all lung NETs respectively, and AC tend to be more aggressive. Although both can metastasise, AC are more likely; common sites include bone and liver. Currently, brain imaging is not included in the work-up of TC/AC, as

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Jones J, Spurgeon L, Shaheen F, Lewis A, Mansoor W,

Keywords: typical carcinoid, atypical carcinoid, brain metastases, Ki67,

#3104 Molecular profiling of well-differentiated neuroendocrine tumors: Role of ctDNA

Introduction: Tumor molecular profiling has proven relevant for the clinical management of cancer. Circulating tumor DNA (ctDNA) may be a useful surrogate of tumor tissue when this is insufficient for analysis.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Lamarca A

Authors: Lamarca A, Frizziero M, Barriuso J, Kapacee Z, Mansoor W,

Keywords: ctDNA, well-differentiated, neuroendocrine,

#2084 A Comparison of Diagnostic and Management Pathways for Patients with Lung Neuroendocrine Tumors in ENETS Centres of Excellence vs Non-Accredited Centres in the UK: Results from the National Lung NET Pathway Project (‘LEAP’)

Introduction: The ENETS network of accredited NET Centres of Excellence (CoE) across Europe was established to standardise and improve NET management.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Talbot D

Authors: Talbot D, Ferguson S, Mansoor W,

Keywords: Treatment pathways, Lung NET, Centre of Excellence, ENETS, Diagnostics,

#2002 Pulmonary Function Test Physiology and Progression in Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia

Introduction: Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) is a rare condition characterised by a generalised proliferation of pulmonary neuroendocrine cells within the respiratory epithelium. Little is known of its affects on pulmonary function both at the time of diagnosis and prospectively.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Barlow J

Authors: Barlow J, Ryan D, Mansoor W, Howell M, Clayton N,

Keywords: Neuroendocrine, Cell, Pulmonary, Function, Hyperplasia, Pulmonary function, Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, DIPNECH, Physiology,

#1849 Mixed Adeno-Neuroendocrine Carcinoma (MANEC) of the Gastrointestinal (GI) Tract: Experience of a European Neuroendocrine Tumour Society (ENETS) Centre of Excellence

Introduction: Knowledge of MANECs is limited

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Frizziero M, Wang X, Chakrabarty B, Mansoor W, Fulford P,

Keywords: manec, gastroinstestinal tract, overall survival,